Conference
The Neurokinin-1 Receptor Antagonist Orvepitant Is A Novel Anti-Tussive Therapy For Chronic Refractory Cough: Results From A Phase 2 Study (volcano-1)
Authors
Smith JA; Allman D; Badri H; Miller R; Morris J; Satia I; Wood A; Trower M
Volume
195
Publisher
AMER THORACIC SOC
Publication Date
January 1, 2017
Name of conference
International Conference of the American-Thoracic-Society (ATS)
Conference place
Washington, DC
Conference start date
May 19, 2017
Conference end date
May 24, 2017
Conference proceedings
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN
1073-449X